Identified PAH V230A and PAH V230I mutations in a family with diverse clinical presentations
Autor: | Faeze Khaghani, Peyman Eshraghi, Tayebeh Hamzehloei |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2024 |
Předmět: | |
Zdroj: | Clinical Case Reports, Vol 12, Iss 3, Pp n/a-n/a (2024) |
Druh dokumentu: | article |
ISSN: | 2050-0904 92541178 |
DOI: | 10.1002/ccr3.8598 |
Popis: | Key Clinical Message Phenylketonuria (PKU) is a hereditary disorder caused by phenylalanine hydroxylase enzyme (PAH) defects that might cause severe brain damage. The current main treatment, dietary management, can prevent the symptoms if commenced early. However, it has side effects if used for a long time. Additionally, some patients with mild hyperphenylalaninemia (mHPA), who has serum phenylalanine levels |
Databáze: | Directory of Open Access Journals |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |